Literature DB >> 1984452

B cell activation during HIV-1 infection. II. Cell-to-cell interactions and cytokine requirement.

A Amadori1, R Zamarchi, M L Veronese, M Panozzo, A Barelli, A Borri, M Sironi, F Colotta, A Mantovani, L Chieco-Bianchi.   

Abstract

This study examined the mechanisms underlying the intense activation of HIV-1-specific B cells observed in peripheral blood of HIV-1-infected subjects. Spontaneous in vitro synthesis of anti-HIV-1 antibodies, as well as total Ig production, were dramatically reduced by accessory cell, but not T cell removal. This fall was counteracted by addition of rIL-6, but not other cytokines, to monocyte-depleted cultures; moreover, antisera against IL-6 suppressed spontaneous anti-HIV-1 antibody synthesis in a dose-dependent manner. Although IL-6 apparently sustained HIV-1-specific B cell activation, no increase in serum IL-6 levels was observed; PBMC from seropositive subjects did not produce increased amounts of IL-6 in vitro, compared to seronegative controls, both spontaneously and in the presence of LPS stimulation; finally, no constitutive expression of IL-6 gene could be documented in freshly isolated PBMC. These findings indicate that IL-6 may play a central role in HIV-1-specific B cell activation in seropositive patients, and further stress the importance of this cytokine during HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1984452

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy.

Authors:  S Resino; I Galán; A Pérez; J A León; E Seoane; D Gurbindo; M Angeles Muñoz-Fernandez
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

Review 2.  B cell responses to HIV and the development of human monoclonal antibodies.

Authors:  J E Boyd; K James
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

3.  Immunoglobulin and complement complexes in blood following infection with human immunodeficiency virus type 1.

Authors:  X X Peng; M A Wainberg; Y Tao; B G Brenner
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

4.  Loss of memory B cells during chronic HIV infection is driven by Foxo3a- and TRAIL-mediated apoptosis.

Authors:  Julien van Grevenynghe; Rafael A Cubas; Alessandra Noto; Sandrina DaFonseca; Zhong He; Yoav Peretz; Abdelali Filali-Mouhim; Franck P Dupuy; Francesco A Procopio; Nicolas Chomont; Robert S Balderas; Elias A Said; Mohamed-Rachid Boulassel; Cecile L Tremblay; Jean-Pierre Routy; Rafick-Pierre Sékaly; Elias K Haddad
Journal:  J Clin Invest       Date:  2011-09-19       Impact factor: 14.808

5.  HIV-induced IL-6/IL-10 dysregulation of CD4 cells is associated with defective B cell help and autoantibody formation against CD4 cells.

Authors:  R Weimer; S Zipperle; V Daniel; R Zimmermann; K Schimpf; G Opelz
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

6.  Increased expression of interferon-gamma in hyperplastic lymph nodes from HIV-infected patients.

Authors:  M J Boyle; M F Berger; M Tschuchnigg; J E Valentine; B G Kennedy; M Divjak; D A Cooper; J J Turner; R Penny; W A Sewell
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

7.  In vitro immunotoxicity of +/- 2'-deoxy-3'-thiacytidine, a new anti-HIV agent.

Authors:  G Lisignoli; M C Monaco; A Degrassi; S Toneguzzi; E Ricchi; P Costigliola; A Facchini
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

8.  B cell activation and human immunodeficiency virus infection. V. Phenotypic and functional alterations in CD5+ and CD5- B cell subsets.

Authors:  S Indraccolo; M Mion; R Zamarchi; A Veronesi; M L Veronese; M Panozzo; C Betterle; A Barelli; A Borri; A Amadori
Journal:  J Clin Immunol       Date:  1993-11       Impact factor: 8.317

9.  Cytokine profiles in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy.

Authors:  Brian M Jones; Susan Ss Chiu; Wilfred Hs Wong; Wilina Wl Lim; Yu-Lung Lau
Journal:  J Int AIDS Soc       Date:  2005-05-03       Impact factor: 5.396

10.  Defective IL-6 secretion in HIV-infected haemophilia patients.

Authors:  R Weimer; S Zipperle; V Daniel; R Zimmermann; G Opelz
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.